113337-72-7 Usage
Purpose
Chemotherapy drug used to treat various types of cancers (e.g. breast, lung, ovarian)
Mechanism
Interferes with the growth and spread of cancer cells in the body
Classification
Anthracycline class of medications
Administration
Typically administered intravenously
Side Effects
May include nausea, vomiting, hair loss, and increased risk of infection, among others
Precaution
It is important to consult with a healthcare professional before using Epirubicin to understand the potential risks and benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 113337-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,3,3 and 7 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 113337-72:
(8*1)+(7*1)+(6*3)+(5*3)+(4*3)+(3*7)+(2*7)+(1*2)=97
97 % 10 = 7
So 113337-72-7 is a valid CAS Registry Number.
113337-72-7Relevant academic research and scientific papers
Synthesis of 3-(4-Cyclopentene-1,3-dione-2-ylidene)-6-(diphenylmethylene)cyclohexadienes as Novel p-Quinodimethanes Stabilized by Antiaromaticity of Cyclopentadienone
Toda, Mitsuo,Hattori, Makiko,Okada, Keiji,Oda, Masaji
, p. 1263 - 1266 (2007/10/02)
Title compounds, whose polarization is decreased by antiaromaticity of cyclopentadienone, have been synthesized through a novel Rh(II)-catalyzed arylation of cyclic 2-diazo-1,3-diones.
